SCHEMBL23196471

SCHEMBL23196471

CC(C)(C)OC(=O)NCCCCNC(=O)/C=C/c1ccccc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.67
EGFR P00533 2/20 0.65
RAB9A P51151 2/20 0.59
NPC1 O15118 1/20 0.59
HDAC3 O15379 1/20 0.59
HDAC4 P56524 1/20 0.59
HDAC1 Q13547 1/20 0.59
HDAC7 Q8WUI4 1/20 0.59
HDAC2 Q92769 1/20 0.59
HDAC10 Q969S8 1/20 0.59
HDAC11 Q96DB2 1/20 0.59
HDAC8 Q9BY41 1/20 0.59
HDAC6 Q9UBN7 1/20 0.59
HDAC9 Q9UKV0 1/20 0.59
HDAC5 Q9UQL6 1/20 0.59
MMP1 P03956 1/20 0.55
POLB P06746 1/20 0.55
MMP2 P08253 1/20 0.55
MMP9 P14780 1/20 0.55
RECQL P46063 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29830593 1.00 KMT2A (0.67) KMT2AEGFRRAB9ANPC1HDAC3
SCHEMBL29992174 0.89 RAB9A (0.57) KMT2AEGFRRAB9ANPC1MMP1
SCHEMBL22882086 0.89 RAB9A (0.57) KMT2AEGFRRAB9ANPC1MMP1
SCHEMBL31344550 0.85 EGFR (0.48) KMT2AEGFRHDAC3HDAC4HDAC1
SCHEMBL3208177 0.84 KMT2A (0.93) KMT2AEGFRRAB9ANPC1HDAC3
SCHEMBL31344552 0.84 EGFR (0.50) KMT2AEGFRRAB9ANPC1HDAC3
SCHEMBL27218420 0.84 KMT2A (0.51) KMT2AEGFRRAB9ANPC1HDAC3
SCHEMBL27218419 0.84 KMT2A (0.51) KMT2AEGFRRAB9ANPC1HDAC3
SCHEMBL29992177 0.84 AKR1B10 (0.51) KMT2AEGFRRAB9ASMN1; SMN2LMNA
SCHEMBL22882087 0.84 AKR1B10 (0.51) KMT2AEGFRRAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021063942-A1 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2021-04-08 WO disclosed